Mostrar o rexistro simple do ítem

dc.contributor.authorPeña-Peña, Maria Luisa
dc.contributor.authorOchoa, Juan Pablo
dc.contributor.authorBarriales-Villa, Roberto
dc.contributor.authorCicerchia, Marcos
dc.contributor.authorPalomino-Doza, Julián
dc.contributor.authorSalazar-Mediguchia, Joel
dc.contributor.authorLamounier, Arsonval
dc.contributor.authorTrujillo-Quintero, Juan Pablo
dc.contributor.authorGarcía-Giustiniani, Diego
dc.contributor.authorFernández, Xusto
dc.contributor.authorOrtiz-Genga, Martín
dc.contributor.authorMonserrat, Lorenzo
dc.contributor.authorCrespo-Leiro, María Generosa
dc.date.accessioned2020-06-05T12:22:23Z
dc.date.issued2020-05-01
dc.identifier.citationPeña-Peña ML, Ochoa JP, Barriales-Villa R, et al. Prognostic implications of pathogenic truncating variants in the TTN gene. Int J Cardiol. 2020es_ES
dc.identifier.issn1874-1754
dc.identifier.issn0167-5273
dc.identifier.urihttp://hdl.handle.net/2183/25686
dc.description.abstract[Abstract] Introduction and objectives: TTN gene truncating variants (TTNtv) are a frequent cause of dilated cardiomyopathy (DCM). However, there are discrepant data on the associated prognosis. Our objectives were to describe the prevalence of TTNtv in our cohort and to compare the clinical course with that described in the literature. Methods: We included patients with DCM and genetic testing performed using next-generation sequencing. Through a systematic literature research, we collected information about carriers and affected relatives with TTNtv. We compared the cumulative percentage of affected carriers and the survival free of cardiovascular death. Results: One hundred and ten DCM patients were evaluated. A total of 13 TTNtv distributed in 14 probands were identified (12.7%). We found a 21.4% prevalence in familial cases. No significant differences in the relation between age and clinical disease expression were identified. Survival free of cardiovascular death curves constructed from data in the literature seems not to overestimate the risk in our population. Conclusions: The identification of TTNtv in patients with DCM is frequent and provides relevant information about the disease prognosis. The risk of cardiovascular death should not be underestimated. Age related penetrance need to be considered in the familial evaluation.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.urihttps://doi.org/10.1016/j.ijcard.2020.04.086es_ES
dc.rightsAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)es_ES
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDilated cardiomyopathyes_ES
dc.subjectGenetic testinges_ES
dc.subjectMutationes_ES
dc.titlePrognostic Implications of Pathogenic Truncating Variants in the TTN Genees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/embargoedAccesses_ES
dc.date.embargoEndDate2021-05-01es_ES
dc.date.embargoLift2021-05-01
UDC.journalTitleInternational Journal of Cardiologyes_ES


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem